A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 156.94
GOOG 908.32
MSFT 71.99
BAC 23.56
FB 166.24

Recently Added

ATHM 63.78
ANDV 92.98
APEN 4.43
CALA 14.02
ISIG 1.00

Gaining Speed

ANDV 92.98
APEN 4.43
ATHM 63.78
PSA 196.96
OHI 31.47

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!